Year: 2017
Type: article
Abstract: E arly clinical trials (1,2) and basic physiology studies (3) have shown that there can be significant benefit from renal denervation (RDN) for reducing hypertension.More recently, however, a well-controlled clinical trial (SYMPLICITY HTN-3 [Renal Denervation in Patients With Uncontrolled Hypertension-3]) (4) suggests that this benefit may not be so clear cut.There are good reasons to From the Heart and Vascular Research Center, MetroHealth Campus, Case Western Reserve University, Cleveland, Ohio.This paper was supported, in part, by National Institutes of Health grant HL123012 (to Dr. Laurita).Dr. Wilson has received a research compound for use in basic science experiments from
Authors: Lance D. Wilson, Kenneth R. Laurita
Institutions: MetroHealth, Case Western Reserve University
Language: English
Subfield: Cardiology and Cardiovascular Medicine
Field: Medicine
Domain: Health Sciences
Open Access status: gold
Estimated APC paid: $4,750
Award: G3592073470
OpenAlex ID: W2609008797
